• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.
Advanced
search
ALL

Synonyms(0)

Find out more technical terms

Thesaurus Map Clips

ー



Please login to MyJ-GLOBAL to use J- GLOBAL.
Please register to create your MyJ-GLOBAL account, if you do not have one.
What is MyJ-GLOBAL?
Login Register now
Number of clips is over the max size. (Max number of Clips: 600)
Close
Reset
Go to 「How to search」 page
Advanced search: Search from
　
　Select basic information for advanced search
Free word
～
Chemical structure search
How to Search
Import

MOLfile format is only available (V3000 format is not available)

              
Rchr
J-GLOBAL ID：201901014844646174   Update date: Mar. 17, 2025

Yuta Myojin

ミョウジン ユウタ | Yuta Myojin
Affiliation and department：
Osaka University

About Osaka University


Research field  (1)： Gastroenterology
Research theme for competitive and other funds  (2)：
  • 2021 - 2023 癌微小環境において肝星細胞が肝癌細胞増殖に与える機序の解明
  • 2019 - 2021 Liver cancer cells manipulate stromal cells involved in fibrosis to promote tumor growth
Papers (26)：
  • Mohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, Benjamin Ruf, Yuta Myojin, Kylynda C Bauer, Patrick Huang, Chi Ma, Marina Villamor-Payà, Francisco Rodriguez-Matos, et al. Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME. Immunity. 2025
  • Yuta Myojin, Sepideh Babaei, Rajiv Trehan, Christoph Hoffman, Noemi Kedei, Benjamin Ruf, Mohamed-Reda Benmebarek, Kylynda C Bauer, Patrick Huang, Chi Ma, et al. Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab. Gut. 2025
  • Shusuke Kumazaki, Hayato Hikita, Yuki Tahata, Ji Hyun Sung, Kenji Fukumoto, Yuta Myojin, Sadatsugu Sakane, Kazuhiro Murai, Yoichi Sasaki, Kumiko Shirai, et al. Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis. Alimentary pharmacology & therapeutics. 2024
  • Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Tatsuya Sakamoto, Ryohei Narumi, Jun Adachi, Naruyasu Kakita, Yukinori Yamada, Hidenori Toyoda, Hirokazu Takahashi, et al. Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD. Hepatology communications. 2024. 8. 6
  • Kylynda C Bauer, Rajiv Trehan, Benjamin Ruf, Yuta Myojin, Mohamed-Reda Benmebarek, Chi Ma, Matthias Seifert, Amran Nur, Jonathan Qi, Patrick Huang, et al. The Gut Microbiome Controls Liver Tumors via the Vagus Nerve. bioRxiv : the preprint server for biology. 2024
ｍore...
MISC (41)：
  • Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Ryohei Narumi, Jun Adachi, Ryotaro Sakamori, Naruyasu Kakita, Yukinori Yamada, Tatsuya Sakamoto, Machiko Kai, et al. SERUM Fibulin3 IS A NOVEL FIBROSIS MARKER IN NAFLD REVEALED BY PROTEOMIC ANALYSIS OF SERUM EXTRACELLULAR VESICLES. HEPATOLOGY. 2022. 76. S801-S801
  • Yuta Myojin, Hayato Hikita, Yuki Tahata, Akira Doi, Yoichi Sasaki, Kumiko Shirai, Sadatsugu Sakane, Ryoko Yamada, Takahiro Kodama, Ryotaro Sakamori, et al. GROWTH DIFFERENTIATION FACTOR 15 AS A NOVEL BIOMARKER FOR HEPATOCELLULAR CARCINOMA AFTER HCV ELIMINATION. HEPATOLOGY. 2021. 74. 543A-544A
  • Kenji Fukumoto, Hayato Hikita, Yoichi Sasaki, Seiya Kato, Yuta Myojin, Sadatsugu Sakane, Kazuhiro Murai, Yuki Makino, Takahiro Kodama, Ryotaro Sakamori, et al. SUPPRESSION OF MACROPHAGE AUTOPHAGY PROGRESSES THE PATHOLOGY OF NAFLD / NASH WITH CELLULAR SENESCENCE OF LSEC. HEPATOLOGY. 2021. 74. 1089A-1089A
  • 小玉尚宏, 明神悠太, 村井大毅, 前阪和城, 山田涼子, 疋田隼人, 阪森亮太郎, 巽智秀, 竹原徹郎. 分子免疫プロファイルに基づいた肝細胞がんに対する薬物療法の治療戦略. 日本肝がん分子標的治療研究会プログラム・抄録集. 2021. 24th
  • 村井一裕, 疋田隼人, 加藤聖也, 下田彬允, 工藤慎之輔, 福岡誠, 福富啓祐, 明神悠太, 佐藤克彦, 田畑優貴, et al. 慢性肝疾患患者における新型コロナウイルスIgG抗体陽性率の検討. 日本消化器病学会雑誌(Web). 2021. 118
ｍore...
Education (2)：
  • 2016 - 2021 大阪大学大学院 医学系研究科
  • 2005 - 2011 Osaka University Faculty of Medicine Medical School
Professional career (2)：
  • Ph.D. (Osaka University)
  • M.D. (Osaka University)
Work history (5)：
  • 2025/04 - 現在 National Cancer Institute Special Volunteer
  • 2025/04 - 現在 大阪大学大学院医学系研究科 消化器内科学 医員
  • 2021/07 - 2025/03 National Cancer Institute Visiting Fellow
  • 2015/04 - 2021/07 大阪大学大学院医学系研究科 消化器内科学 医員
  • 2011/04 - 2015/03 関西労災病院 医員
Awards (10)：
  • 2024/07 - NIH Fellows Award for Research Excellence (FARE)
  • 2024/01 - The JSPS Japanese Research Fellowship at NIH (KAITOKU-NIH)
  • 2021/12 - 第6回Gastro-PLUS 優秀賞
  • 2021/11 - 日本消化器関連学会機構 若手奨励賞
  • 2021/11 - 日本肝臓学会 冠アワード(Abbvie Award)
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM